Antithrombotic therapy and progression of coronary artery disease: Antiplatelet versus antithrombins

Circulation

Volumn 86, Issue 6 SUPPL., 1992, Pages

  Chesebro, J H ^a   Webster, M W I ^a   Zoldhelyi, P ^a   Roche, P C ^a   Badimon, L ^a   Badimon, J J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

antiplatelet therapy; coronary artery disease; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; FIBRIN; HEPARIN; HIRUDIN; THROMBIN;

ANGIOCARDIOGRAPHY; ARTERY THROMBOSIS; BLOOD CLOT LYSIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; HEART INFARCTION; HUMAN; INCIDENCE; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOGENICITY;

ASPIRIN; BLOOD PLATELETS; CORONARY DISEASE; FIBRINOLYTIC AGENTS; HEPARIN; HUMAN; LIPIDS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBIN; THROMBOSIS;

EID: 0007667220     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)